QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
QQQ   444.01 (-0.18%)
AAPL   171.48 (-1.06%)
MSFT   420.72 (-0.17%)
META   485.58 (-1.68%)
GOOGL   150.93 (+0.04%)
AMZN   180.38 (+0.31%)
TSLA   175.79 (-2.25%)
NVDA   903.56 (+0.12%)
NIO   4.50 (-3.64%)
AMD   180.49 (+0.50%)
BABA   72.36 (+1.08%)
T   17.60 (+0.28%)
F   13.28 (+1.68%)
MU   117.89 (-1.14%)
CGC   8.63 (-9.63%)
GE   175.53 (-2.55%)
DIS   122.36 (+1.14%)
AMC   3.72 (-14.29%)
PFE   27.75 (-0.11%)
PYPL   66.99 (+0.63%)
XOM   116.24 (+1.10%)
NASDAQ:ABSI

Absci (ABSI) Stock Price, News & Analysis

$5.68
+0.14 (+2.53%)
(As of 04:00 PM ET)
Today's Range
$5.51
$5.76
50-Day Range
$3.41
$5.74
52-Week Range
$1.11
$6.40
Volume
1.20 million shs
Average Volume
1.57 million shs
Market Capitalization
$640.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.25

Absci MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
63.7% Upside
$9.25 Price Target
Short Interest
Bearish
13.25% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
-0.09mentions of Absci in the last 14 days
Based on 18 Articles This Week
Insider Trading
Acquiring Shares
$999,999 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.77) to ($0.65) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.91 out of 5 stars

Medical Sector

632nd out of 939 stocks

Commercial Physical Research Industry

9th out of 10 stocks

ABSI stock logo

About Absci Stock (NASDAQ:ABSI)

Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver, Washington.

ABSI Stock Price History

ABSI Stock News Headlines

Absci's (ABSI) Buy Rating Reaffirmed at Truist Financial
Absci's (ABSI) "Outperform" Rating Reaffirmed at Scotiabank
AI to Meet the Same Fate as EVs?
When these tech bubbles burst, they invariably leave investors disillusioned by their losses. Now, many worry a similar fate is awaiting AI. And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11…
Absci's (ABSI) "Buy" Rating Reiterated at HC Wainwright
Absci: Q4 Earnings Insights
AI to Meet the Same Fate as EVs?
When these tech bubbles burst, they invariably leave investors disillusioned by their losses. Now, many worry a similar fate is awaiting AI. And one man, legendary financial analyst Porter Stansberry, who called Nvidia at $11…
ABSI Apr 2024 6.000 call
TD Cowen Keeps Their Buy Rating on AbSci (ABSI)
Why Absci (ABSI) Shares Are Falling
Absci Announces Pricing of Public Offering of Common Stock
Absci Announces Proposed Public Offering of Common Stock
CNC Mar 2024 86.000 call
ABSI Mar 2024 7.500 call
ABSI Feb 2024 7.500 put
See More Headlines
Receive ABSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Absci and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/21/2024
Today
3/28/2024
Next Earnings (Estimated)
5/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Commercial physical research
Sub-Industry
N/A
Current Symbol
NASDAQ:ABSI
Fax
N/A
Employees
193
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$9.25
High Stock Price Target
$13.00
Low Stock Price Target
$7.00
Potential Upside/Downside
+63.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-110,570,000.00
Net Margins
-1,933.65%
Pretax Margin
-1,931.90%

Debt

Sales & Book Value

Annual Sales
$5.72 million
Book Value
$1.90 per share

Miscellaneous

Free Float
99,724,000
Market Cap
$639.52 million
Optionable
Optionable
Beta
2.35
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives


ABSI Stock Analysis - Frequently Asked Questions

Should I buy or sell Absci stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Absci in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ABSI shares.
View ABSI analyst ratings
or view top-rated stocks.

What is Absci's stock price target for 2024?

4 equities research analysts have issued 1 year target prices for Absci's shares. Their ABSI share price targets range from $7.00 to $13.00. On average, they anticipate the company's stock price to reach $9.25 in the next twelve months. This suggests a possible upside of 63.7% from the stock's current price.
View analysts price targets for ABSI
or view top-rated stocks among Wall Street analysts.

How have ABSI shares performed in 2024?

Absci's stock was trading at $4.20 at the beginning of the year. Since then, ABSI stock has increased by 34.5% and is now trading at $5.65.
View the best growth stocks for 2024 here
.

When is Absci's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our ABSI earnings forecast
.

How were Absci's earnings last quarter?

Absci Co. (NASDAQ:ABSI) announced its quarterly earnings results on Thursday, March, 21st. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.23) by $0.02. The business had revenue of $0.34 million for the quarter, compared to analysts' expectations of $1.75 million. Absci had a negative trailing twelve-month return on equity of 44.52% and a negative net margin of 1,933.65%.

When did Absci IPO?

Absci (ABSI) raised $200 million in an initial public offering (IPO) on Thursday, July 22nd 2021. The company issued 12,500,000 shares at a price of $15.00-$17.00 per share.

Who are Absci's major shareholders?

Absci's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (2.77%), Vanguard Group Inc. (2.77%), Platinum Investment Management Ltd. (0.90%), Hsbc Holdings PLC (0.44%), Charles Schwab Investment Management Inc. (0.38%) and Bridgeway Capital Management LLC (0.29%). Insiders that own company stock include Karen K Mcginnis, Redmile Group, Llc, Sarah Korman, Sean Mcclain and Todd Bedrick.
View institutional ownership trends
.

How do I buy shares of Absci?

Shares of ABSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ABSI) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners